ABL:ETR
Abbott Laboratories
€98.86
arrow_upward
+1.00%(+0.98) 1D
Nov 11, 3:40:16 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABL...
Open
€98.38
High
€99.10
Low
€97.90
Mkt. cap
189.66B
Avg. vol.
860.00
Volume
654.00
52-wk high
€113.36
52-wk low
€70.10
No. of employees
115K
Open
€98.38
High
€99.10
Low
€97.90
Mkt. cap
189.66B
Avg. vol.
860.00
Volume
654.00
52-wk high
€113.36
52-wk low
€70.10
No. of employees
115K
News stories
From web sources and news partners
Yahoo Finance UK
·
1 day ago
Gene Amplification Technologies - Global Strategic Business Report: Capture $4.4B in New Revenue by 2030 as Abbott, Bio-Rad, bioMerieux, Cepheid and Becton Dickinson Battle for Share
Yahoo Finance
·
1 day ago
What Are Wall Street Analysts' Target Price for Abbott Stock?
JournalArta
·
2 days ago
Abbott Laboratories (ABT) Stock: $109.93, Down 3.23% Nov 6
MarketWatch
·
4 days ago
Abbott Laboratories stock underperforms Friday when compared to competitors
Profile
Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company founded in Chicago with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.
Abbott operates in over 160 countries and sources from at least 62 suppliers worldwide. Abbott's products include Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip.
The company is ranked 107th on the Fortune 500 and 144th on the Forbes Global 2000. Wikipedia
About Abbott Laboratories
CEORobert B. Ford
Employees115K
Founded1888
HeadquartersChicago, Illinois, United States
SectorHealth Care
IndustryMedical device
Websiteabbott.com